TRiCares has initiated the US pivotal IDE study for its Topaz Transcatheter Tricuspid Valve Replacement (TTVR) system, marking the first randomized trial comparing it head-to-head with the Edwards EVOQUE system. This global, multi-center study aims to evaluate the safety and effectiveness of Topaz in patients with severe tricuspid regurgitation, involving up to 75 sites across the US, Canada, and Europe. The study's start is a key step toward FDA approval and wider adoption of Topaz as a minimally invasive alternative to open-heart surgery for tricuspid valve replacement. Ongoing parallel studies in Europe and early feasibility studies in the US and Canada support the clinical development of Topaz.
A new comprehensive report from ResearchAndMarkets.com reviews 50,011 patents filed globally from 2010 to 2025 on energy optimization technologies, with China leading the filings. The report highlights key innovation areas such as building efficiency...
A new report reveals the surgical navigation system market, valued at $8.38 billion in 2024, is projected to grow to $18.47 billion by 2030 with a 14% CAGR. Key growth drivers include AI-guided support, augmented reality, and robotic integration, par...
A new report reveals the United States and China dominate RF-detection technology patents, holding 490 and 479 patents respectively out of 1,248 filed globally from 2010 to 2024. The global RF-detection market, valued at $3.5 billion in 2023, is expe...
InStride's Capability Accelerators program won the "Best Professional Development Solution of the Year" at the 8th EdTech Breakthrough Awards. The program offers cohort-based, role-specific training designed to close skill gaps aligned with business ...
Stella-Jones Inc. will hold a conference call on August 6, 2026, at 10:00 AM EST to discuss its second quarter financial results for 2026. The call will be accessible via webcast and phone, with a recording available afterward. Stella-Jones is a majo...
